CONSORTIUM FOR RAPID COVID-19 DRUG DEVELOPMENT IN AFRICA

(COVIDRUG-AFRICA CONSORTIUM)

We are a multidisciplinary consortium working to rapidly identify new compounds for development as remedies for COVID-19. In particular, our work is aimed at developing drugs targeting SARS-CoV-2 strains predominant in Africa. To achieve this, we are using and developing model systems that take into account genetic variations prevalent in African populations.